Today's Earnings Calls Pulse
Synopsys posts record FY2025 revenue and secures $2B Nvidia investment
Synopsys reported FY2025 revenue of $7.05 billion, up 15% year‑over‑year, and a backlog of $11.4 billion. Q4 revenue hit $2.25 billion, beating guidance, while non‑GAAP operating margin rose to 37.3% and EPS exceeded forecasts. The company also announced a $2 billion strategic equity investment from Nvidia and plans to prepay $2.55 billion of obligations.
TOMI Environmental Solutions Inc (TOMZ) Q4 2025 Earnings Call Transcript
Thermo Fisher Scientific reported Q4 2025 revenue of $12.21 billion, a 7% year‑over‑year increase, and full‑year revenue of $44.56 billion, up 4%. Adjusted EPS rose 8% in the quarter to $6.57 and 5% for the year to $22.87, while adjusted operating margin held at 23.6% despite a 100‑basis‑point tariff and FX headwind. The company deployed $16.5 billion in capital, including $13 billion of acquisitions and a $9 billion definitive agreement to acquire Clario, expected to add roughly $0.45 of adjusted EPS in 2026. Guidance for 2026 projects 4‑6% revenue growth, 3‑4% organic growth, and 6‑8% adjusted EPS growth, with further upside from Clario’s integration.
Faraday Future Intelligent Electric Inc (FFAI) Q4 2025 Earnings Call Transcript
Ford Motor Company reported $187 billion revenue for 2025, marking its fifth consecutive year of top‑line growth, and generated $6.8 billion adjusted EBIT after absorbing $2 billion each from Novelis fire losses and a tariff headwind. U.S. market share rose to 13.2%, the...
NextPlat Corp (NXPL) Q4 2025 Earnings Call Transcript
NextPlat Corp reported a 29% year‑over‑year revenue increase for the first half of fiscal 2025, marking its seventh straight double‑digit growth quarter. The company’s backlog surged to a record $4.5 billion, with 90% now expected to be realized over the next...
Direct Digital Holdings Inc (DRCT) Q4 2025 Earnings Call Transcript
Direct Digital Holdings (DRCT) posted Q4 2025 revenue of $206 million, up 8% year‑over‑year, and full‑year revenue of $748 million, up 14% YoY, delivering a 38% adjusted EBITDA margin for the quarter and 33% for the year. Growth was driven by a...
Tvardi Therapeutics Inc (TVRD) Q4 2025 Earnings Call Transcript
Teva reported Q4 2025 revenue of $4.5 billion, up 3% year‑over‑year, with adjusted EBITDA rising 6% and non‑GAAP EPS of $0.78, a 14% increase. The innovative portfolio contributed over $800 million, driven by AUSTEDO’s $618 million U.S. sales (+38%) and solid gains from...
Lanzatech Global Inc (LNZA) Q4 2025 Earnings Call Transcript
Lazard Ltd. reported $3 billion in full‑year 2025 revenue, highlighted by a record $1.8 billion Financial Advisory haul and a 12% rise in assets under management to $261 billion. Q4 revenue reached $892 million, up 10% YoY, while Asset Management generated $339 million, an 18%...
Chagee Holdings Ltd (CHA) Q4 2025 Earnings Call Transcript
Chegg reported $18 million in Q4 2025 revenue from its newly emphasized Chegg Skilling unit, signaling the start of double‑digit growth in the $40 billion corporate‑learning market. Adjusted EBITDA reached $13 million, an 18% margin that exceeded the high end of guidance,...
ClearSign Technologies Corp (CLIR) Q4 2025 Earnings Call Transcript
ClearSign Technologies reported Q4 2025 results, with revenue climbing to $133,000 from $45,000 and net loss narrowing by roughly $200,000. Cash burn fell to $511,000, leaving $12.3 million in cash and equivalents. Management highlighted two cornerstone burner projects—a 20‑burner installation in...
Skillz Inc (SKLZ) Q4 2025 Earnings Call Transcript
Playtika reported Q4 2025 revenue of $678 million, a modest sequential rise and 4.4% year‑over‑year growth, driven largely by a 19.5% jump in direct‑to‑consumer (D2C) sales. Casual titles now account for 74% of total revenue, reflecting a strategic pivot away from...
PVH Corp (PVH) Q4 2026 Earnings Call Transcript
G-III Apparel Group reported fourth‑quarter net sales of $771 million, a 8% decline year‑over‑year, as the company completed its exit from Calvin Klein and Tommy Hilfiger licenses, shedding $254 million in revenue. Owned brands such as DKNY, Donna Karan, Karl Lagerfeld and Vilebrequin now...
Omeros Corp (OMER) Q4 2025 Earnings Call Transcript
Omeros Corp reported a Q3 2025 net loss of $30.9 million, but secured a transformative agreement with Novo Nordisk that could deliver up to $2.1 billion in upfront and milestone payments. The $240 million upfront cash will retire most short‑term debt and fund more...
Meridian Holdings Inc (MRDN) Q4 2025 Earnings Call Transcript
Sound Point Meridian Capital reported a sharp decline in net asset value to $14.02 per share for Q4 2025, driven by mark‑to‑market pressure on CLO equity valuations as buyer demand faded. Net investment income of $9 million fell short of the...
Venu Holding Corp (VENU) Q4 2025 Earnings Call Transcript
Garmin reported a record Q4 2025 with consolidated revenue of $2.13 billion, up 17% year‑over‑year, and full‑year revenue of $7.25 billion, a 15% increase. Operating margin expanded to 28.9% in the quarter, delivering $614 million of operating income and a pro‑forma EPS of...
Solesence Inc (SLSN) Q4 2025 Earnings Call Transcript
Solesence Inc. reported Q4 2025 revenue of $14.5 million, a 14% year‑over‑year decline, with gross margin falling to 23% from 36% and a net loss of $1.1 million. The company highlighted a surge in open orders to $64 million, reflecting continued demand...
Rekor Systems Inc (REKR) Q4 2025 Earnings Call Transcript
Rekor Systems posted a record $14.2 million Q4 revenue, up 35% year‑over‑year, and saw recurring revenue rise 18% to $6.5 million. Adjusted gross margin jumped to 63% from 44% a year earlier, while operating expenses fell 24% quarter‑over‑quarter, narrowing the adjusted EBITDA...
Brainstorm Cell Therapeutics Inc (BCLI) Q4 2025 Earnings Call Transcript
Bristol‑Myers Squibb reported flat Q4 2025 revenue of $12.5 billion, with its growth portfolio expanding 15% YoY to $7.4 billion, offsetting roughly $4 billion of legacy decline. The company guided 2026 revenue between $46 billion and $47.5 billion, projecting 10‑15% growth for Eliquis despite a...
DSS Inc (DSS) Q4 2025 Earnings Call Transcript
Distribution Solutions Group (DSG) reported fiscal 2025 revenue of $1.98 billion, up 9.8% despite one fewer selling day, and generated $84 million of operating cash flow. Adjusted EBITDA fell to $175 million, reflecting an 8.9% margin, down from 9.7% a year earlier, while...
JJill Inc (JILL) Q4 2026 Earnings Call Transcript
Genesco Inc. reported fiscal 2026 fourth‑quarter revenue of $800 million, a 7% year‑over‑year increase, with company‑wide comparable sales rising 9%. Journeys led growth, delivering 12% comparable sales and expanding its 4.0 store format to 84 locations, targeting a fleet share of...
Allbirds Inc (BIRD) Q4 2025 Earnings Call Transcript
Allbirds reported Q4 2024 net revenue of $56 million, in line with guidance, and a modestly better-than-expected adjusted EBITDA loss of $19 million. The company highlighted cost discipline, cutting SG&A by over $20 million and closing 15 U.S. stores while...
Lithium Corp (LTUM) Q4 2025 Earnings Call Transcript
Lithia Motors reported record Q4 revenue of $9.2 billion, lifting full‑year sales to $37.6 billion, a 4% increase. Adjusted diluted EPS climbed 16% year‑over‑year to $33.46, driven by strong used‑vehicle and aftersales growth. Margin pressure persisted, with total vehicle GPU down $258...
Interactive Strength Inc (TRNR) Q4 2025 Earnings Call Transcript
Integer Holdings reported an 8% rise in full‑year sales to $1.85 billion, with organic growth exceeding 6%, and a 21% jump in adjusted EPS to $6.40. Adjusted operating margin expanded to 17.3%, driven by higher gross margins and disciplined expense control....
HCW Biologics Inc (HCWB) Q4 2025 Earnings Call Transcript
Hercules Capital reported record Q4 2025 performance, originating $1.06 billion in new debt and reaching nearly $4 billion in annual originations. Platform‑level assets under management grew 20.5% to $5.7 billion, while GAAP leverage rose modestly to 104.4%, remaining at the low end of...
Galectin Therapeutics Inc (GALT) Q4 2025 Earnings Call Transcript
Altimmune reported a strengthened cash position of roughly $340 million, extending its runway through 2028 to fund a pivotal Phase III NASH trial. The company disclosed that the trial will enroll about 1,800 patients globally, testing 1.8 mg and 2.4 mg doses of its...
ENDRA Life Sciences Inc (NDRA) Q4 2025 Earnings Call Transcript
Schneider National reported fourth‑quarter 2025 revenue of $1.3 billion, up 4% year‑over‑year, but adjusted earnings per share fell to $0.13, a 35% decline. The quarter was marred by a truncated peak season, severe Midwest weather, and auto‑production shutdowns that compressed margins,...
BTQ Technologies Schedules Shareholder Call to Unveil 2025 Results and Corporate Outlook
BTQ Technologies Corp. will host a live shareholder webcast on March 31, 2026, at 12:00 p.m. EST to release its 2025 financial statements and provide a corporate update. The call, led by CEO Olivier Roussy Newton, aims to outline the company’s progress...
CFOs Emphasize Efficiency, Reaching 2020 Highs
The year of efficiency is back Chief financial officers at large U.S. companies mentioned “efficiency” at least once on 307 conference calls in the latest quarter as of March 26, up from 219 a year earlier and the highest level...
Micron Beats FY2026 Q2 Forecast, Shaking Analyst Doubts on AI Memory Demand
Micron Technology reported fiscal Q2 2026 results that exceeded consensus estimates, despite recent analyst concerns that AI‑driven memory demand could soften. The earnings surprise helped steady the stock, which remains a key tech holding in the S&P 500.
Cava Group Targets 76 New Restaurants in 2026, Aiming for $184M EBITDA
Cava Group announced a plan to open 74 to 76 new restaurants in 2026, seeking $176‑$184 million in adjusted EBITDA. The strategy follows a record‑setting fourth quarter that lifted the stock 41% year‑to‑date and pushed annual revenue past $1 billion.
Darden's Olive Garden Boosts Q3 Sales with GLP-1 Menu and Free Food Promo
Darden Restaurants' CEO Rick Cardenas announced GLP-1‑friendly smaller portions and an expanded Buy One, Take One promotion during the Q3 FY2026 earnings call. The changes helped Olive Garden post a 4.7% rise in total sales, driven by menu innovation and...
Adobe Posts $125M AI‑driven ARR, Lifts FY2026 Revenue Guide as CEO Steps Down
Adobe announced its first AI‑centric annual recurring revenue (ARR) of $125 million for Q1, raised its FY2026 revenue outlook to $26.1 billion, and said CEO Shantanu Narayen will hand over the role once a successor is named. The moves highlight early AI...
Fermi Inc (FRMI) Q4 2025 Earnings Call Transcript
Ferroglobe reported Q4 2025 revenue of $329 million, up 6% sequentially, driven by a 13% rise in shipments of silicon‑based and manganese alloys. The company secured new trade safeguards in the EU and antidumping duties in the US, opening roughly 100,000‑110,000 tons...
Innventure Inc (INV) Q4 2025 Earnings Call Transcript
InvenTrust Properties Corp. reported a 5.3% same‑property NOI increase for 2025, driven by rent escalations, occupancy gains and strong leasing spreads. NAREIT FFO rose 6.2% to $1.89 per share and core FFO to $1.83, while the board lifted the annual...
DiaMedica Therapeutics Inc (DMAC) Q4 2025 Earnings Call Transcript
ADMA Biologics reported a robust 2025 year, posting $510.2 million in revenue—a 20% increase year‑over‑year—driven primarily by rapid growth of its specialty IVIG product Ascentive. Adjusted EBITDA rose 40% to $231 million and adjusted net income climbed 35% to $160.8 million, reflecting strong...
Sensei Biotherapeutics Inc (SNSE) Q4 2025 Earnings Call Transcript
Senseonics reported full‑year 2025 revenue of $35.3 million, a 60 % YoY increase, and lifted gross margin above 50 % after moving commercial operations in‑house. Q4 net revenue reached $14.3 million, while net loss narrowed to $20.8 million despite higher operating costs. The company secured...
Actinium Pharmaceuticals Inc (ATNM) Q4 2025 Earnings Call Transcript
Actinium Pharmaceuticals reported adjusted 2025 revenue of $1.08 billion, a 14% increase year‑over‑year, driven by strong performance of its two core brands. NUPLAZID generated $692 million in adjusted net sales, up 15%, while DAYBUE posted $391 million, up 12%, aided by a 30%...
DeFi Development Corp (DFDV) Q4 2025 Earnings Call Transcript
Definium Therapeutics reported that its lead psychedelic candidate DT120 ODT is on track for three pivotal Phase III readouts in 2026. The EMERGE MDD study is fully enrolled with top‑line data expected in late Q2, while the VOYAGE GAD trial...
Progress Software Corp (PRGS) Q1 2026 Earnings Call Transcript
Progress Software reported fiscal 2025 revenue of $978 million, a 30% year‑over‑year increase, driven largely by the full‑year contribution of its ShareFile acquisition. Earnings per share rose 16% to $5.72, and the fourth‑quarter operating margin hit 38%, surpassing guidance. ARR reached...
Guided Therapeutics Inc (GTHP) Q4 2025 Earnings Call Transcript
G1 Therapeutics announced FDA approval of COSELA, a first‑in‑class therapy that reduces chemotherapy‑induced myelosuppression in extensive‑stage small cell lung cancer. The company began commercial launch in early February 2021, reporting rising physician awareness and positive payer feedback. It also outlined...
Phreesia Inc (PHR) Q4 2026 Earnings Call Transcript
Phreesia reported Q4 FY2026 revenue of $117.3 million, up 15% YoY, and posted its first GAAP net‑income positive quarter at $0.7 million. The company announced a definitive agreement to acquire AccessOne for $160 million in cash, a deal expected to add $35 million of...
Nakamoto Inc (NAKA) Q4 2025 Earnings Call Transcript
Nasdaq (NASDAQ) reported full‑year 2025 net revenue of $5.2 billion, up 12% YoY, with solutions revenue surpassing $4 billion. Operating income rose 16% to $2.9 billion, delivering a 56% operating margin and a 24% increase in diluted EPS. The company achieved record index...
Boston Omaha Corp (BOC) Q4 2025 Earnings Call Transcript
Boston Omaha Corp reported $38 million revenue for the first nine months of 2025, a 28% year‑over‑year increase, driven by record performance and strong international demand, especially in India. Net income rose 54% to $2.8 million, reflecting profit leverage as the defense‑focused...
USA Rare Earth Inc (USAR) Q4 2025 Earnings Call Transcript
Ultragenyx Pharmaceutical reported 2025 revenue of $673 million, a 20% year‑over‑year increase that topped the upper end of guidance. The company announced a 10% workforce reduction to streamline costs and focus on near‑term value drivers. Pipeline highlights include resubmission of...
Lexeo Therapeutics Inc (LXEO) Q4 2025 Earnings Call Transcript
Exelixis reported record cabozantinib franchise revenue of $2.12 billion in the U.S. and $2.89 billion globally for 2025, a 17% year‑over‑year increase. Total Q4 2025 revenue reached $599 million, driven by $546.6 million from cabozantinib net product sales and $52.8 million in partner royalties. The...
Lantern Pharma Inc (LTRN) Q4 2025 Earnings Call Transcript
nLIGHT Inc. reported a record full‑year 2025 revenue of $261 million, a 32% increase year‑over‑year, driven by a 60% surge in its aerospace and defense (A&D) segment to $175 million. The company posted an all‑time quarterly revenue of $81.2 million in Q4, with...
CXApp Inc (CXAI) Q4 2025 Earnings Call Transcript
CXApp Inc. reported Q4 2025 revenue of $1.1 million, down as the company deliberately phased out hardware sales, while gross margin climbed to 89% thanks to tighter cloud cost management. Operating expenses fell 8% to $4.8 million, narrowing the net loss to...
Bicara Therapeutics Inc (BCAX) Q4 2025 Earnings Call Transcript
Bausch Health Companies reported Q4 2025 revenue of $1.4 billion, a 9% year‑over‑year increase, and adjusted EBITDA of $773 million, up 9% and ahead of guidance. Full‑year results showed 7% reported revenue growth and double‑digit adjusted EBITDA expansion without major acquisitions. The...
Oxbridge Re Holdings Ltd (OXBR) Q4 2025 Earnings Call Transcript
Corebridge Financial reported a strong fourth‑quarter 2025, posting adjusted pretax operating income of $760 million and operating EPS of $1.22, a 15% year‑over‑year increase. Total sales reached a record $42 billion, up 4%, while the company returned $2.6 billion to shareholders, lifting the...
Prairie Operating Co (PROP) Q4 2025 Earnings Call Transcript
Permian Resources Corp reported Q4 2025 results that beat its own guidance, delivering 401,500 barrels of oil equivalent per day of production and $403 million adjusted free cash flow. The company lowered drilling‑and‑completion costs to $700 per foot and reduced lease...
Airjoule Technologies Corp (AIRJ) Q4 2025 Earnings Call Transcript
Airgain Technologies reported Q4 2025 revenue of $12.1 million, matching the low end of its guidance, while full‑year revenue fell 15% to $51.8 million. The company improved its non‑GAAP gross margin to 46.3% and kept operating expenses flat, but posted a negative...
RenovoRx Inc (RNXT) Q4 2025 Earnings Call Transcript
RenovoRx reported Q4 2025 revenue of $266,000, bringing year‑to‑date sales to roughly $900,000 as it expands the RenovoCath platform across 14 approved cancer centers, up from five earlier in the year. The company ended the quarter with over $10 million in...